![Ely Benaim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ely Benaim
Keine laufenden Positionen mehr
Profil
Ely Benaim ist Chief Medical Officer bei NovoCure Ltd. In der Vergangenheit hatte Dr. Benaim die Position des Vice President-Clinical Affairs bei Sangamo Therapeutics, Inc. inne, Chief Medical Officer & SVP-Regulatory Affairs bei Berg Pharma LLC, Senior Director-Clinical Research bei Millennium Pharmaceuticals, Inc, Chief Medical Officer von Rexahn Pharmaceuticals, Inc, Senior Director-Global Oncology bei Salmedix, Inc. und Assistenzprofessor an der University of Tennessee. Dr. Benaim erhielt einen Doktortitel von der Central University of Venezuela.
Ehemalige bekannte Positionen von Ely Benaim
| Unternehmen | Position | Ende |
|---|---|---|
| NOVOCURE LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 17.01.2023 |
| REXAHN PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2019 |
Berg Pharma LLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
| SANGAMO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Ausbildung von Ely Benaim
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
University of Tennessee
 University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Central University of Venezuela
 Central University of Venezuela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Berg Pharma LLC |
